Gilead Sciences Inc (GILD)
66.94
-0.38
(-0.56%)
USD |
NASDAQ |
Apr 17, 16:00
66.94
0.00 (0.00%)
After-Hours: 16:58
Gilead Sciences Total Long Term Debt (Quarterly): 24.99B for Dec. 31, 2023
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 24.99B |
September 30, 2023 | 24.98B |
June 30, 2023 | 25.25B |
March 31, 2023 | 25.24B |
December 31, 2022 | 25.23B |
September 30, 2022 | 25.22B |
June 30, 2022 | 26.22B |
March 31, 2022 | 26.21B |
December 31, 2021 | 26.70B |
September 30, 2021 | 27.69B |
June 30, 2021 | 30.18B |
March 31, 2021 | 30.17B |
December 31, 2020 | 31.40B |
September 30, 2020 | 29.29B |
June 30, 2020 | 24.10B |
March 31, 2020 | 24.10B |
December 31, 2019 | 24.59B |
September 30, 2019 | 24.59B |
June 30, 2019 | 26.08B |
March 31, 2019 | 26.58B |
December 31, 2018 | 27.32B |
September 30, 2018 | 27.32B |
June 30, 2018 | 29.06B |
March 31, 2018 | 29.05B |
December 31, 2017 | 33.54B |
Date | Value |
---|---|
September 30, 2017 | 29.26B |
June 30, 2017 | 26.30B |
March 31, 2017 | 26.32B |
December 31, 2016 | 26.35B |
September 30, 2016 | 27.07B |
June 30, 2016 | 22.13B |
March 31, 2016 | 22.82B |
December 31, 2015 | 22.06B |
September 30, 2015 | 22.22B |
June 30, 2015 | 12.27B |
March 31, 2015 | 12.36B |
December 31, 2014 | 12.40B |
September 30, 2014 | 9.410B |
June 30, 2014 | 9.505B |
March 31, 2014 | 9.804B |
December 31, 2013 | 6.636B |
September 30, 2013 | 7.313B |
June 30, 2013 | 7.338B |
March 31, 2013 | 7.998B |
December 31, 2012 | 8.224B |
September 30, 2012 | 8.771B |
June 30, 2012 | 9.099B |
March 31, 2012 | 9.429B |
December 31, 2011 | 7.607B |
September 30, 2011 | 3.893B |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
24.10B
Minimum
Mar 2020
31.40B
Maximum
Dec 2020
26.43B
Average
25.25B
Median
Jun 2023
Total Long Term Debt (Quarterly) Benchmarks
Amgen Inc | 64.61B |
Johnson & Johnson | 29.33B |
Eli Lilly and Co | 25.23B |
CymaBay Therapeutics Inc (DELISTED) | 109.17M |
Arcus Biosciences Inc | 0.00 |